로딩 중…
지수 로딩 중…
Vanda Pharmaceuticals Inc.
VNDA· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$5.80-2.68%
2026-06-18
Price Chart
Vanda Pharmaceuticals Inc.+28.04%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $349M |
| Revenue | $218M |
| Net Income | $-240M |
| Total Assets | $434M |
| Net Assets | $281M |
| Value | |
| P/B | 1.24x |
| P/S | 1.60x |
| FCF Yield | -36.50% |
| Profitability | |
| ROE | -85.32% |
| ROA | -55.26% |
| Op. Margin | -73.64% |
| Revenue Growth | 3.35% |
| Financial Health | |
| Debt Ratio | 54.41% |
| Total Debt | $13M |
| FCF | $-127M |
| Cash | $54M |
| Current Ratio | 2.16x |
| Performance | |
| 1Y Return | 28.04% |
| 1M Return | -3.17% |
| From 52W High | -41.65% |
| 1Y MDD | -40.06% |
| Trading | |
| Volume | 1,566,380 shares |
| Trading Value | $9M |
| Per Share | |
| EPS | $-3.73 |
| BPS | $5.54 |